Quick answer
The first month on Wegovy at the 0.25mg starter dose is intentionally the lightest step in titration. Most patients experience: appetite reduction within 3-7 days (the desired pharmacologic effect), mild nausea peaking 24-48 hours after each weekly injection, mild GI symptoms (diarrhea, constipation, or both alternating), and approximately 2% body weight loss by week 4 based on STEP-1 trial data. The first month establishes your tolerance baseline — if you handle 0.25mg well, the full 16-week titration is usually manageable. About 5% of patients discontinue during titration; the remaining 95% adapt with proper management.
1. What to expect the first month
The first month covers the entire 0.25mg dose phase. This is the lowest dose Wegovy is manufactured at — intentionally low to establish your tolerance baseline before escalation. Pharmacologically, 0.25mg semaglutide is sufficient to engage GLP-1 receptors for appetite reduction but generates only mild GI side effects in most patients. The trial-averaged outcomes:
- Weight loss: ~2% body weight by week 4 (STEP-1 cohort)
- Appetite reduction: Noticeable within days 3-7 in 70-80% of patients
- Nausea incidence: ~25% report mild nausea, ~5% moderate-severe
- Discontinuation: ~5% of patients quit during full titration, most often in weeks 1-4 or weeks 13-16
The biggest predictor of long-term success: tolerating the first month. Patients who establish good habits early (protein-first eating, hydration, injection-day planning) typically continue them through full titration.
2. Week 1: First injection day-by-day
The first injection is psychologically harder than physiologically. Pharmacokinetically, semaglutide reaches peak plasma concentrations around 24-72 hours post-injection — so day 2-3 is when symptoms typically begin.
- Day 1 (injection day): Usually uneventful. Mild fatigue some report. Plan injection for late evening if you can — symptoms peak when sleeping.
- Days 2-3: Peak nausea window. Most common: morning queasiness, mid-morning food aversion, occasional headache. Eat smaller meals, hydrate.
- Day 4: Symptoms typically beginning to ease. Some patients notice the "food noise quieting" effect — intrusive food thoughts diminishing.
- Days 5-7: Often the easiest days of week 1. Most patients report return to near-normal with slightly reduced appetite.
Why most patients overestimate first-week intensity
Patients come in expecting severe nausea based on internet horror stories — and most are surprised the first week is gentler than expected. The 0.25mg starter dose is barely enough to cause significant symptoms in ~75% of patients. The real challenge comes when you titrate to 1.0mg around week 9 — that's the dose where many patients first feel the medication.
3. Week 2: Adaptation begins
Week 2 typically brings the same injection-day cycle as week 1, but slightly amplified as semaglutide reaches steady-state. About 4-5 weekly doses are needed for full steady-state plasma concentrations. Patterns:
- Appetite reduction now noticeable for most patients (food noise quieting)
- Mild nausea pattern repeats but typically less severe (body adapting)
- GI symptoms may shift — some patients move from nausea-dominant to constipation-dominant
- Sleep may be lighter; some patients wake briefly mid-night
4. Week 3: New baseline emerges
By week 3, most patients have established their "new normal" eating pattern: smaller meal volume, longer satiety between meals, less interest in snacking, increased water intake. Weight loss begins becoming visible on the scale (1-2 lb typical). The body has substantially adapted to weekly semaglutide exposure — symptoms continue diminishing.
Watch for: increased thirst (drink 2-3L/day), occasional constipation as appetite drops (increase fiber + fluids), reduced caffeine tolerance for some patients.
5. Week 4: Pre-escalation steady state
The last week before the first dose escalation (0.25mg → 0.5mg). Typically the most comfortable week of titration — body fully adapted to current dose, baseline symptoms minimal. Use this week to:
- Confirm your eating habits are sustainable (protein adequate, hydration consistent)
- Take baseline measurements (weight, body fat, circumference) for tracking
- Plan injection timing around upcoming dose escalation symptoms
- Schedule prescriber check-in if dose increase is delayed for any reason
Week 5 brings 0.5mg — symptoms may briefly reset. Expect a mild repeat of week 2 intensity.
6. Side effect timeline visualization
Visualizing typical severity across the first 12 weeks helps set expectations:
Side-effect timeline
When side effects peak (and when they resolve)
Typical severity arc over the first 12 weeks of titration. Most GI side effects peak weeks 2-4 of each dose increase and resolve as the body adapts. Individual experience varies.
Source: STEP-1, SURMOUNT-1, SCALE-Obesity adverse-event reporting + patient survey aggregations. Severity arcs are typical patterns; individual experiences vary substantially.
7. What to eat (week-by-week food strategy)
Week 1: Bland + protein
Keep meals simple and predictable while you learn your tolerance. Best foods: Greek yogurt + berries, scrambled eggs, plain chicken + rice, oatmeal, cottage cheese, lean turkey, sweet potato, steamed vegetables. Avoid: greasy/fried foods, large portions, high-sugar items, raw vegetables in large quantities, alcohol.
Week 2: Expand carefully
Add variety as week 1 tolerance permits. Reintroduce: salads (with light dressing), fish, beans/legumes, more diverse vegetables, fresh fruits. Watch for individual triggers — some patients identify specific foods (red meat, dairy, specific spices) that worsen GI symptoms.
Week 3: Establish maintenance pattern
Aim for 4-6 small meals daily, protein-first (target 0.7-1g per pound goal body weight), adequate fiber (25-35g daily), hydration 2-3L. This is your titration eating pattern — establish it now, refine later.
Week 4: Optimize for sustainability
Identify 5-10 "safe meals" you enjoy and tolerate well. These become your go-to options during future titration weeks when GI sensitivity peaks. Stock pantry/fridge accordingly.
8. When to call your prescriber
Most first-month symptoms are manageable at home. Call your prescriber for:
- Severe persistent vomiting preventing fluid retention >24 hours (dehydration risk)
- Severe abdominal pain especially radiating to back (pancreatitis screening)
- Signs of allergic reaction (rash, throat swelling, breathing difficulty — call 911 if severe)
- Blood in vomit or stool
- Severe dehydration signs: dark urine, dizziness, rapid heartbeat, confusion
- Hypoglycemia symptoms if on insulin or sulfonylureas (sweating, shakiness, confusion)
- Persistent mood changes or thoughts of self-harm — call 988 immediately
9. Frequently asked questions
- How bad is the first month of Wegovy?
- Most patients experience mild-to-moderate nausea peaking 1-3 days after each injection at the 0.25mg starter dose, resolving by day 5-7. Severity varies widely — about 30-40% report noticeable nausea, 5-10% experience significant symptoms requiring management strategies, and ~5% discontinue due to intolerability. The starter dose is intentionally low (0.25mg) precisely because the first month establishes tolerance — week 4 is typically the easiest week of titration.
- What should I eat during the first month of Wegovy?
- Stick to protein-first eating: 4-6 small meals daily, lean proteins (chicken, fish, tofu, Greek yogurt), bland complex carbs (rice, oats, sweet potato), and easily digestible vegetables. Avoid: greasy/fried foods, large meals, high-sugar items, alcohol, and dehydrating foods. Many patients find cold or room-temperature foods tolerate better than hot during nausea-prone moments. Target 0.7-1g protein per pound goal weight to preserve lean mass during weight loss.
- When does Wegovy nausea peak in the first month?
- Nausea typically peaks 24-48 hours after each weekly injection at the 0.25mg starter dose, then declines through days 3-7. The pattern repeats with each dose escalation. First-month peak is usually mild; the more challenging windows come later when escalating to 1.0mg (week 9) and 1.7mg (week 13). Patients who tolerate the first month typically tolerate the full titration with manageable symptoms.
- How much weight will I lose the first month on Wegovy?
- Average first-month weight loss on Wegovy is approximately 2% of starting body weight (~4 lb for a 200-lb starting weight), based on STEP-1 trial cohort data. Individual results vary substantially: some patients lose 1-2%, others 4-5%. The starter 0.25mg dose is intentionally low to build tolerance, not maximize early loss. Major weight loss begins weeks 5-12 as the dose escalates.
- Can I drink alcohol during my first month of Wegovy?
- No FDA contraindication, but practical advice: avoid alcohol during the first 2 weeks while you learn your tolerance. Alcohol amplifies GI side effects (nausea, dehydration) and reduced food intake means lower stomach buffer — same drink count produces more intense effects. After week 2, if you tolerate Wegovy well, occasional moderate drinking is typically OK. Start with half your previous tolerance and drink with food. See our GLP-1 + alcohol guide for full evidence review.
Next reading
Related guides
Individual experience varies. This is educational, not medical advice. Always consult your prescriber. Full disclaimer.